Cellectis Net Other Investing Changes (Quarterly) Analysis

Cellectis SA (CLLS)

3.95 +0.05 (+1.28%) USD | NASDAQ | Feb 23, 13:03

View Net Other Investing Changes (Quarterly) for CLLS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Other Investing Changes (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Other Investing Changes (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Other Investing Changes (Quarterly) Benchmarks

Start Trial

EDAP TMS SA	--
DBV Technologies SA	Upgrade
Ascendis Pharma A/S	--
Akari Therapeutics Plc	--
Biodexa Pharmaceuticals Plc	--